Prof. Dr. Olga Golubnitschaja

• President of European Association for Predictive, Preventive & Personalised Medicine (EPMA, epmanet.eu) and its founding member

• Head of the world's first department for 3P medicine (at Rheinische Friedrich-Wilhelms-Universität Bonn)

• Editor-in-Chief of the EPMA Journal, SpringerNature (IF 8.836, CiteScore 11.3), springer.com/journal/13167

• Editor-in-Chief of the book series “Ad­van­ces in Predictive, Preventive and Per­so­na­lised Medicine”, SpringerNature, springer.com/series/10051

• Author of more than 400 international publications (research and review articles, position papers, books, book and congress contributions) in the innovative field of 3P medicine with research focus on: suboptimal health conditions, pre- and perinatal diagnostics, diagnostics of stress-related diseases, diagnostics of cardiovascular diseases and neurodegenerative diseases, predictive diagnostics in cancer and diabetes

• Vice-Chair in the “Marie Curie” programme at European Commission in Brussels. In 2010-2013, she was involved in creating the 3P medicine-related contents of the European programme “Horizon 2020”.

• Education in journalism, biotechnology and medicine

• Several international awards in biomedical research

Dr. Vincenzo Costigliola

• Graduate in Medicine from the University of Naples and with distinction in Anaesthesiology and Intensive Care from the University of Pisa; additional studies in Rheumatology, Dermatology, Proctology, Oncology, Surgery, Drugs Abuse, Emergency Treatment, Disaster Action, Hospital Organization, Medical Teaching Methodology and Computer and Audio-Visual Training for the Medical Profession

• President of European Medical Association (EMA, emanet.org), Honorary President of EPMA and its founding member, President of European Depression Association (EDA, europeandepressionday.eu) and board member of many other medical institutions

Dr. Kurt Krapfenbauer

• Ph.D. and master’s degree in chemistry (both degrees from University of Vienna)

• Inventor of more than 9 international patents, leading to the Roche Inventory Award 2005

• Author of more than 55 scientific publications on Biochemical Research

• Experience as laboratory head at Hoffman LaRoche, and as head of Biomarker Research at the Novartis Institutes for Biomedical Research in Basel, Switzerland. His responsibilities have included Research & Development, Manufacturing Operations, Technical Operations and Quality Assurance.

• Postgraduate study with a degree as a “Qualified Person”

• Extensive experience as senior scientist in Biomarker research including development and validation of Biomarker essays

• Founding member of EPMA with following functions:
2008-2021: Vice President for European Affairs
since 2021: Vice President for International Affairs

Dr. Marko Kapalla

• Specialized Clinical Biochemist, Natural scientist, Quality manager (ISO 15 189)

• Ph.D. in Normal and Pathological Physiology

• EPMA vice-president for European Affairs (since 2021) and its founding member

• National representative of EPMA in Slovakia

• Associate editor of the EPMA Journal, SpringerNature

• CEO of “PPPM Centre, s.r.o.” (pppmc.sk)

Dr. Jiří Polívka

• Department of Histology and Embryology, research at the University Hospital Plzeň and at the Biomedical Center, Faculty of Medicine in Plzeň, Charles University

• Doctoral study (at the Faculty of Medicine in Plzeň, Charles University) in General Medicine: Anatomy, Histology and Embryology

• Fields of activity: oncology, neuro-oncology, preventive oncology, neurosciences and clinical chemistry

• Secretary General of EPMA (since 2021)

• Editorial board member of the EPMA Journal and of the book series “Ad­van­ces in Predictive, Preventive and Personalised Medicine”, SpringerNature

• (Co-)Author of 47 publications, having more than 1250 citations. H index 19.

• Awards:
2012 The Josef Hlavka Prize
2014 Prize of the Plzeň Region

Michel Joseph Girard

• Graduate in business administration, entrepreneur

Thomas Scherenhorst

• Graduate in business administration, tax consultant

Dr. jur. Pavel Labuda, LL.M. (Cologne/Paris I)

• CEO of “3PMedicon GmbH”

• Lawyer, EPMA Director responsible for Legal Affairs (since 2017)